| dc.contributor.author | Macdonald, Orla | |
| dc.contributor.author | Smith, Katharine A | |
| dc.contributor.author | Marven, Michael | |
| dc.contributor.author | Broughton, Nick | |
| dc.contributor.author | Geddes, John R | |
| dc.contributor.author | Cipriani, Andrea | |
| dc.date.accessioned | 2020-12-10T13:56:03Z | |
| dc.date.available | 2020-12-10T13:56:03Z | |
| dc.date.issued | 2020-11 | |
| dc.identifier.citation | Orla Macdonald, Katharine Smith, Michael Marven, Nick Broughton, John Geddes, Andrea Cipriani. How pharmacist prescribers can help meet the mental health consequences of COVID-19. Based Ment Health November 2020 Vol 23 No 4 | en |
| dc.identifier.issn | 1468-960X | |
| dc.identifier.uri | https://oxfordhealth-nhs.archive.knowledgearc.net/handle/123456789/662 | |
| dc.description | Freely available online for the duration of the COVID-19 pandemic | en |
| dc.description.abstract | We suggest that Mental Health Trusts
should urgently develop prescribing roles
for specialist mental health pharmacists,
which are integrated within mental health
teams. In these roles, prescribing pharmacists can actively support their multidisciplinary colleagues in case discussion
meetings. Furthermore, they should host
regular medication review clinics, where
patients can be referred to discuss their
medicine options and, as advancements
in precision therapeutics continue, have
their treatment individually tailored to
their needs. This is the way forward for a
modern and patient-oriented NHS in the
UK | en |
| dc.description.sponsorship | supported by the NIHR | en |
| dc.description.uri | http://dx.doi.org/10.1136/ebmental-2020-300210 | en |
| dc.language.iso | en | en |
| dc.subject | Prescribing | en |
| dc.subject | Mental Health Services | en |
| dc.subject | COVID-19 | en |
| dc.subject | Pharmacists | en |
| dc.title | How pharmacist prescribers can help meet the mental health consequences of COVID-19 | en |
| dc.type | Article | en |